JiangXi NanChang Pharmaceutical Co., Ltd.
-
Founded in:
2004-07-19 -
Country:
China -
Address:
No. 929, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Nanchang City, Jiangxi Province -
Tax NO.:
91360121158634281L -
Registered Funds:
23.716 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| ASIAN GINSENG |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| Salvia Root P.E Tanshinone IIA 20% |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| Hawthorn |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| Ophiopogonis Radix |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| lycii Fructus |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 | ||
| Fleeceflower root HRS |
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum.
More
It has the effect of preventing myocardial ischemia-reperfusion injury. It reduces the content of malondialdehyde (MDA) in isolated rat myocardium, reduces tissue calcium accumulation, reduces the content of protein and lactate dehydrogenase (LDH) in coronary artery outflow fluid, and increases the calcium adenosine triphosphatase activity of myocardial sarcoplasmic reticulum. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
125mg | 103-90-2 | 68 |
| Chlorphenamine maleate |
It is an antihistamine that can relieve symptoms such as runny nose, nasal congestion, and sneezing.
More
It is an antihistamine that can relieve symptoms such as runny nose, nasal congestion, and sneezing. |
0.5mg | 113-92-8 | 28 |
| Atificial Cow-bezoar |
Antipyretic and sedative effects
More
Antipyretic and sedative effects |
5mg | 1002-00-2 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gliclazide |
Sulfonylurea is an oral hypoglycemic diabetes treatment drug. It lowers blood sugar levels by stimulating pancreatic β cells to secrete insulin, restores the first phase insulin secretion peak in response to glucose and increases the first phase insulin secretion. The insulin secretion response induced or stimulated by glucose after a meal is significantly increased. At the same time, it reduces the microthrombosis process by partially inhibiting platelet adhesion and aggregation and reducing platelet activity markers (p-thromboglobulin, thromboxane B2); it produces fibrinolytic activity on the vascular endothelium (increases tPA activity).
More
Sulfonylurea is an oral hypoglycemic diabetes treatment drug. It lowers blood sugar levels by stimulating pancreatic β cells to secrete insulin, restores the first phase insulin secretion peak in response to glucose and increases the first phase insulin secretion. The insulin secretion response induced or stimulated by glucose after a meal is significantly increased. At the same time, it reduces the microthrombosis process by partially inhibiting platelet adhesion and aggregation and reducing platelet activity markers (p-thromboglobulin, thromboxane B2); it produces fibrinolytic activity on the vascular endothelium (increases tPA activity). |
21187-98-4 | 22 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 | ||
| Sucrose |
|
57-50-1 | 73 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dried leaf extract |
|
0 | ||
| Chlorphenamine maleate |
|
113-92-8 | 28 |